The recombinant zoster vaccine protects adults with HIV against cardiovascular complications such as incident heart failure ...

Patients with type 2 diabetes and atrial fibrillation or atrial flutter who start GLP-1 drugs may have a lower risk for ...

Amiodarone: a) Preferred in atrial flutter b) Is a class II antiarrhythmic agent c) Has many adverse effects d) Has a short half-life e) Pulmonary fibrosis is a notable side effect ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. In a pair of late-stage trials, a ...

Many patients with chronic obstructive pulmonary disease (COPD) have exacerbations despite receiving standard-of-care inhaled maintenance therapy. Dysregulated interleukin-33 signaling is implicated ...

The relationship between right atrial (RA) structural and functional remodeling and risk of incident atrial fibrillation/flutter (AF/AFL) in pulmonary arterial hypertension remains poorly defined. The ...

The National Turf Writers and Broadcasters board of directors shared a letter sent to the executive leadership at FanDuel and Flutter Entertainment, expressing concerns regarding the decision to phase ...

4 Newcastle Upon Tyne Hospital NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK Objective We aimed to compare cryoballoon pulmonary vein isolation (PVI) with standard radiofrequency ...

It’s a simple question that physicians usually do not ask their patients: “When was your last drink?” “If the patient says yesterday, you know the patient isn’t a casual drinker,” said Joe G. Zein, MD ...

EP Aficionado and #EnSite mapping specialist, North Washington State. I collect ECGs and localization algos. This is not medical advice, just personal tweets.

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

Chronic obstructive pulmonary disease and cardiovascular diseases are among the leading chronic health burdens worldwide. They share key modifiable risk factors as well as overlapping ...